Entyvio 300 MG vials

Ended Awarded Last action

Contract number
SPE2DR26FCZQ8
Awardee
Awarding agency
Obligated
$49,663

Award facts

Contract value 100% obligated
$49,662.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, with a ceiling value of $49,662.50, for 300 mg vials of Entyvio.

DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency-administered indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. Place of performance is Park Ridge, Illinois. Ultimate completion date is March 9, 2026. Pricing is firm fixed price.

Quick answers

Who was awarded contract SPE2DR26FCZQ8?

SPE2DR26FCZQ8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 6, 2026.

How much is contract SPE2DR26FCZQ8 worth?

The government has obligated $49,663 on SPE2DR26FCZQ8.

Is contract SPE2DR26FCZQ8 an order under another contract?

Yes. SPE2DR26FCZQ8 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.

Was contract SPE2DR26FCZQ8 competed?

The extent of competition for SPE2DR26FCZQ8 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award